Holen Sie sich die Stockscreener-App
14.85
2.69%
-0.41
Handel nachbörslich:
14.76
-0.09
-0.61%
Shoulder Innovations Inc Aktie (SI) Neueste Nachrichten
Shoulder Innovations, Inc.’s Quiet Period Set To End on September 9th (NYSE:SI) - Defense World
Shoulder Innovations, Inc. shares rise 5.18% intraday after Thermo Fisher Scientific completes acquisition of Solventum's Purification & Filtration business. - AInvest
Shoulder Innovations, Inc.’s Quiet Period Will End on September 9th (NYSE:SI) - Defense World
Shoulder Innovations initiated with a Buy at Goldman Sachs - MSN
Shoulder Innovations (NYSE:SI) Rating Lowered to Sell at Wall Street Zen - Defense World
Shoulder Innovations shares rise 2.97% intraday after announcing Q2 2025 earnings release and conference participation. - AInvest
Shoulder Innovations Soars 6.68% on Market Momentum - AInvest
Shoulder Innovations to Report Second Quarter 2025 Financial Results on September 9, 2025 - The Malaysian Reserve
Brokerages Set Shoulder Innovations, Inc. (NYSE:SI) Target Price at $19.60 - Defense World
Shoulder Innovations to Release Q2 2025 Financials and Host Fireside Chat at Morgan Stanley Conference. - AInvest
Morgan Stanley Initiates Coverage of Shoulder Innovations with Overweight Rating - AInvest
Goldman Sachs Initiates Coverage on Shoulder Innovations with Buy Rating, Sets Price Target at $20.00 USD - AInvest
Shoulder Innovations initiated with an Overweight at Piper Sandler - MSN
Shoulder Innovations initiated with a Buy at Jefferies - MSN
Shoulder Innovations (NYSE:SI) Coverage Initiated by Analysts at Jefferies Financial Group - Defense World
Strong Buy Rating for Shoulder Innovations, Inc. Driven by Market Leadership and High Growth Potential - TipRanks
Shoulder Innovations stock initiated with Overweight rating at Morgan Stanley By Investing.com - Investing.com Canada
Buy Rating for Shoulder Innovations, Inc.: Strong Growth Potential in Shoulder Replacement Market - TipRanks
Heartflow, Inc. shares rise 4.03% intraday after Goldman Sachs and Morgan Stanley initiate coverage on Shoulder Innovations. - AInvest
Piper Sandler initiates coverage on Shoulder Innovations with Overweight rating, PT $18. - AInvest
Shoulder Innovations stock initiated with Buy rating by BTIG - Investing.com
Jefferies Initiates Shoulder Innovations at Buy With $19 Price Target - MarketScreener
Goldman Sachs Initiates Shoulder Innovations at Buy With $20 Price Target - MarketScreener
Jefferies initiates Shoulder Innovations stock with Buy rating on market share gains - Investing.com Canada
Piper Sandler initiates Shoulder Innovations stock with Overweight rating By Investing.com - Investing.com Canada
Goldman Sachs initiates coverage on Shoulder Innovations stock with Buy rating - Investing.com Canada
Shoulder Innovations Expands Surgical Solutions with NYSE Listing—Global Brain Invests - thebridge.jp
Med-tech funding rebounds modestly to $18B through July - BioWorld MedTech
Medical Tech Firm Heartflow Jumps 51% After $317 Million IPO - Bloomberg.com
Medical Tech Firm Heartflow Surges 66% After $317 Million IPO - Bloomberg.com
Heartflow raises USD 317M in IPO - Medical Buyer
Medical Tech Firm Heartflow Prices $317 Million IPO Above Range - Bloomberg.com
Shoulder Innovations Stock Jumps 8% On NYSE Debut - MSN
Medical Tech Firm Heartflow Raises IPO Target to $300 Million - Bloomberg
Gilde healthcare buys $1.5 million in shoulder innovations (SI) By Investing.com - Investing.com UK
Gilde healthcare buys $1.5 million in shoulder innovations (SI) - Investing.com
Shoulder Innovations (NYSE:SI) Reaches New 52-Week HighHere's Why - MarketBeat
U.S. IPO Weekly Recap: Figma Smashes Circle’s Record For Best Billion-Dollar IPO Pop - Seeking Alpha
Heartflow prices IPO, Shoulder Innovation joins NYSE - BioWorld MedTech
Shoulder Innovations: Interesting, Not Convinced (NYSE:SI) - Seeking Alpha
Shoulder Innovations falls short of IPO target with $75M raise - Crain's Grand Rapids Business
Shoulder Innovations, Inc. shares fall 6.25% premarket as tech giants' earnings reports and Figma's IPO overshadow the market. - AInvest
NYSE Content Advisory: Pre-market update + Figma valued at over $19 billion in IPO - The Malaysian Reserve
Latham & Watkins Advises Shoulder Innovations in Initial Public Offering - Latham & Watkins LLP
Shoulder Innovations announces pricing of IPO - Medical Buyer
Figma Surges in IPO, Valued at Over $19 Billion - AInvest
NYSE Content Advisory: Pre-market update + Figma valued at over $19 billion in IPO – Company Announcement - Financial Times
Shoulder Innovations Announces Pricing of Initial Public Offering - PR Newswire
Medtech IPOs Spur Talk of Broader US Health-Care Listing Revival - MSN
Shoulder Innovations is an IPO to watch, this analyst says - Cantech Letter
Grand Rapids device maker plans $105M IPO as implant sales surge - Crain's Grand Rapids Business
Shoulder Innovations prices IPO at $15 per share - MarketScreener
Del. Judge Denies $89M Claim In Silvergate Ch. 11 - Law360
0.78%
0.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):